Orange Book product · Generic (ANDA)
SUCCINYLCHOLINE CHLORIDE
SUCCINYLCHOLINE CHLORIDE
At a glance
Jun 12, 2020
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 12, 2020
6 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
SUCCINYLCHOLINE CHLORIDE
Strength
20MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 213229
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SUCCINYLCHOLINE CHLORIDE
- 2021SUCCINYLCHOLINE CHLORIDEBrand (NDA)
NDA 215143 · HIKMA
- —ANECTINEBrand (NDA)
NDA 008453 · SANDOZ
- —QUELICINBrand (NDA)
NDA 008845 · HOSPIRA
- —SUCOSTRINBrand (NDA)
NDA 008847 · APOTHECON
- 2025SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217885 · FRESENIUS KABI USA
- 2025SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217884 · FRESENIUS KABI USA
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 218878 · BAXTER HLTHCARE CORP
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217873 · STERISCIENCE
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 218467 · DR REDDYS
- 2023SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217808 · EUGIA PHARMA
- 2023SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 216127 · MANKIND PHARMA
- 2022SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 216003 · BE PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
